### [2014-05-19](/news/2014/05/19/index.md)

# AstraZeneca rejects the latest, and likely the last, takeover price from Pfizer, close to 70 billion pounds or US$118 billion. 




### Source:

1. [Reuters](http://www.reuters.com/article/2014/05/19/us-astrazeneca-pfizer-idUSBREA3R0H520140519)
1. [Cover Image](http://s1.reutersmedia.net/resources/r/?m=02&d=20140519&t=2&i=898073638&w=&fh=545px&fw=&ll=&pl=&sq=&r=CBREA460M4L00)

### Related:

1. [Drugmaker Pfizer says it will not proceed with its attempted $119 billion bid for AstraZeneca. ](/news/2014/05/26/drugmaker-pfizer-says-it-will-not-proceed-with-its-attempted-119-billion-bid-for-astrazeneca.md) _Context: AstraZeneca, Pfizer_
2. [Because of a nationwide shortage of intravenous sodium bicarbonate (i.e., baking soda solution), United States hospitals are rationing its use in heart surgery, chemotherapy, for patients whose blood is too acidic, and as an antidote to certain poisons. The two primary producers, Amphastar and Pfizer, indicate that supplies will not increase until late June. ](/news/2017/05/22/because-of-a-nationwide-shortage-of-intravenous-sodium-bicarbonate-i-e-baking-soda-solution-united-states-hospitals-are-rationing-its-u.md) _Context: Pfizer_
3. [Pfizer Inc. decides to terminate its $160 billion merger with Allergan, Plc as officials in Washington crack down on corporate inversions. Pfizer will need to pay a $400 million fee to Allergan for expenses relating to the deal. ](/news/2016/04/5/pfizer-inc-decides-to-terminate-its-160-billion-merger-with-allergan-plc-as-officials-in-washington-crack-down-on-corporate-inversions-p.md) _Context: Pfizer_
4. [The U.S. Treasury Department announces new regulations to curb tax-avoiding corporate inversions, i.e., where U.S. companies slash their tax bills by claiming a new tax home overseas, though their core operations and management remain in the United States. The pending $160 billion merger of Pfizer Inc. and Allergan, Plc could be cancelled because of these new rules. ](/news/2016/04/4/the-u-s-treasury-department-announces-new-regulations-to-curb-tax-avoiding-corporate-inversions-i-e-where-u-s-companies-slash-their-tax.md) _Context: Pfizer_
5. [American pharmaceutical companies Pfizer and Allergan, Plc announce plans to merge to form the world's largest drug company. The merger is subject to approval from regulators in the U.S., European Union and elsewhere as well as approval by shareholders of both companies. If approved, the deal will reduce tax revenue paid to the U.S. by approximately $930 million. ](/news/2015/11/23/american-pharmaceutical-companies-pfizer-and-allergan-plc-announce-plans-to-merge-to-form-the-world-s-largest-drug-company-the-merger-is-s.md) _Context: Pfizer_
6. [The Obama Administration through the U.S. Treasury Department will clamp down further on corporate income tax-avoiding inversion deals by U.S. companies with foreign rivals. There is a pending inversion deal between U.S. drug maker Pfizer Inc. and smaller Irish competitor Allergan, Plc. ](/news/2015/11/18/the-obama-administration-through-the-u-s-treasury-department-will-clamp-down-further-on-corporate-income-tax-avoiding-inversion-deals-by-u.md) _Context: Pfizer_
7. [American pharmaceutical company Pfizer announces plans to acquire Hospira at a cost of $17 billion. ](/news/2015/02/5/american-pharmaceutical-company-pfizer-announces-plans-to-acquire-hospira-at-a-cost-of-17-billion.md) _Context: Pfizer_
8. [Pfizer announces plans to release an over-the-counter version of heartburn medication Nexium. ](/news/2014/05/27/pfizer-announces-plans-to-release-an-over-the-counter-version-of-heartburn-medication-nexium.md) _Context: Pfizer_
9. [Nestl and Danone are said to be bidding for the infant nutrition business that Pfizer is about to put up for sale. ](/news/2012/03/2/nestle-and-danone-are-said-to-be-bidding-for-the-infant-nutrition-business-that-pfizer-is-about-to-put-up-for-sale.md) _Context: Pfizer_
10. [A study funded by Pfizer, makers of the smoking cessation drug Varenicline, claims it would be financially wise for governments to fund smoking cessation treatments. ](/news/2010/09/14/a-study-funded-by-pfizer-makers-of-the-smoking-cessation-drug-varenicline-claims-it-would-be-financially-wise-for-governments-to-fund-smok.md) _Context: Pfizer_
